This guide helps a perfume buyer prepare US cosmetic label artwork for qualified review. Labeling is one compliance workstream, not proof of product safety or permission to market. Identify the actual product, claims, package and sales arrangement before applying a rule or exception.
Key Labeling Elements for U.S. Perfumes
A perfume intended to scent the body generally falls within the cosmetic framework; intended claims can affect classification. Use the applicable FD&C Act, FPLA and FDA requirements. The outer retail package, a bottle sold without a carton and a bottle inside a carton do not all have identical panel rules. The sections below identify the review topics.
1. Statement of Identity
For a retail cosmetic package, identify the product on the principal display panel (PDP), using an appropriate common, descriptive or otherwise permitted identity. FDA’s guide explains prominence and orientation; a brand name alone is not always an adequate statement of identity.
2. Net Quantity of Contents
For an ordinary liquid perfume sold as a packaged consumer cosmetic, declare volume in U.S. customary and SI units under 15 U.S.C. 1453(a)(2) and apply 21 CFR 701.13. Use “fl. oz.” for fluid ounces, not “Net Wt.”; the volume basis is 20°C. The illustrative line “1.7 fl. oz. (50 mL)” is rounded: 1.7 U.S. fl. oz. is approximately 50.275 mL. Where the NIST Handbook 133 method applies, its dual-declaration test verifies the larger converted quantity. Confirm the final declaration and fill specification together before printing.
On the outer retail package, or the bottle when sold without a carton, place the declaration on the PDP within its bottom 30%, generally parallel to the base. The bottom-position rule is waived for a PDP of 5 square inches or less; other requirements remain. The inner-container placement waiver in 21 CFR 701.13(f)(2) is conditional. Net-content type height and spacing follow 701.13(f), (h) and (i), based on the PDP area rather than a universal font size.
3. Name and Place of Business
Under 21 CFR 701.12, identify the manufacturer, packer or distributor and its place of business. When the named business is not the manufacturer, use a factual qualifier such as “Distributed by”. The rule specifies the address components and a conditional street-address omission; it does not impose a blanket requirement for a U.S. distributor. Separately, 21 U.S.C. 364e(a), effective 29 December 2024, requires a domestic address, domestic telephone number or electronic contact information through which the responsible person can receive adverse-event reports. The electronic-contact option does not replace the business-name/address rule.
4. Ingredient Declaration
Apply 21 CFR 701.3 to the final formula: use its ingredient naming hierarchy, predominance order and applicable exceptions, including those for ingredients at 1% or less, color additives and incidental ingredients. “INCI” alone is not the complete U.S. naming rule. The declaration normally belongs on an appropriate information panel; tag, small-package and direct-mail options have specific conditions. Fragrance may be declared under 701.3(a), subject to applicable current law and the status of MoCRA fragrance-allergen rulemaking.
5. Warning Statements (if applicable)
Determine warnings from the actual product, intended use, hazards and applicable regulations. FDA has specific provisions for certain products, including self-pressurized cosmetics; a pump spray is not automatically an aerosol. The previously stated universal 80°C/175°F perfume-warning threshold is not established by the sources checked here. Do not select warnings merely to claim reduced liability.
6. Tamper‑Evident Packaging (if applicable)
FDA’s cited tamper-resistant rule concerns specified categories such as liquid oral hygiene and cosmetic vaginal products. It does not establish a universal seal requirement for all retail perfume bottles. Review any other applicable product, retailer or contractual requirement before selecting an optional seal.
Label Review Topics at a Glance
| Review item | Panel/configuration question | Approval evidence |
|---|---|---|
| Identity | Outer/single-package PDP; immediate container also reviewed | Accurate product identity and legible artwork |
| Net contents | Outer PDP placement and size-dependent exception; inner-container rules separately | Actual fill, volume units, conversion and type/spacing review |
| Business identity/address | Applicable information panel and address/qualifier rules | Verified legal entity and permitted address presentation |
| Adverse-event contact | Label contact channel under MoCRA | Functional domestic address/phone or electronic channel for reports |
| Ingredients | Applicable retail information panel and exceptions | Final formula and FDA naming/order review |
| Warnings/seal | Actual product and applicable category-specific duties | Qualified hazard/use review; no universal perfume threshold or seal assumed |
Common Labeling Pitfalls to Avoid
- Confusing volume and weight: Use “fl. oz.” for the applicable liquid-volume declaration, not “Net Wt.”; verify metric/customary scope, conversion and rounding for the actual fill.
- Unsupported claims: Review natural, organic, hypoallergenic and performance language for its intended meaning and supporting evidence.
- Assuming “Fragrance” settles all disclosure: Apply current ingredient rules and monitor the relevant allergen rulemaking before label approval.
- Incorrect type size for net contents: The FDA sets specific minimum font sizes based on the area of the principal display panel. A tiny font on a small bottle can still violate the rules.
- Conflating business identity and adverse-event contact: Check the name/address rule and the separate MoCRA contact requirement; an email option for the latter does not automatically replace the former.
Annotated artwork preparation example
| Illustrative area | Placeholder content | Reviewer annotation |
|---|---|---|
| Outer carton front / PDP | Brand ___; product identity ___; 1.7 fl. oz. (50 mL) | Example only: confirm actual fill, PDP area, position, typography and rounding |
| Outer information panel | Ingredients ___; manufacturer/packer/distributor ___; address ___ | Use final formula and appropriate qualifier; verify naming and address rules |
| Required label contact | Adverse-event contact ___ | Test that the selected channel reaches the responsible person |
| Inner bottle | Identity, net contents, business details and applicable warnings ___ | Review immediate-container duties and specific exceptions; do not simply copy outer-panel logic |
Approval checklist: record the artwork version, actual container dimensions/PDP area, formula and fill versions, business/contact details, claims, applicable warnings, source date, reviewer and disposition. Leave unresolved items open and obtain professional sign-off before print release. This is an annotation table, not approved production artwork.
Primary sources checked on 10 October 2026: FDA Cosmetics Labeling Guide, FDA labeling summary, MoCRA labeling provision, FDA MoCRA overview and official fragrance-allergen rulemaking agenda. Historical guidance wording must be read with applicable current law; the agenda is not a final rule.
Regulatory-text review: 11 October 2026. 21 CFR Part 701 supports the identity, business address, ingredient, net-content and panel rules; Part 740 covers applicable warning provisions and 700.25 covers the specified tamper-resistant categories. The eCFR Title 21 display was current through 7 October 2026; that is not a claim that each clause changed on that date. The linked FPLA and MoCRA statutory texts are the official 2024 editions, read with current FDA material. For the rounded dual-unit example, see NIST Handbook 133 (2026), section 2.3.3.1, items 2–3. Actual artwork approval remains product- and package-specific.
Frequently Asked Questions
Do I have to list fragrance allergens on my perfume label?
MoCRA directs FDA to define fragrance allergens and implement their disclosure by regulation. On 11 October 2026, the official RIN 0910-AI90 agenda entry displayed “Proposed Rule Stage” and a projected November 2026 proposal. That timetable is not an effective final rule. Recheck the published rule and any transition before approving artwork, and do not describe the existing general fragrance declaration as a permanent exemption from disclosure. An old EU count of 26 is not an adequate current EU checklist either.
Can I use the term “hypoallergenic” on my perfume?
Define what “hypoallergenic” would communicate to the intended audience, then obtain qualified claim and safety review with appropriate support. Do not use the term as a guarantee that reactions cannot occur or infer substantiation from a generic patch test.
What if my perfume bottle is too small to fit all the required information?
Ask the reviewer to apply the specific small-package, display-card, decorative-container or off-package provisions to the actual configuration. A peel-back label or tag is not a blanket waiver. Review both the retail package and immediate container, including readability and any remaining required information.
Does a perfume sold only online need the same labeling as a retail product?
Online sales do not remove applicable physical cosmetic labeling duties. Review the product as supplied to the customer, including the bottle/carton configuration and any applicable exceptions; website information does not automatically replace required package information.
For a project discussion, Request a Quote with the destination, claims, formula version, fill and packaging artwork. Confirm separately who performs qualified US label review and what is included in the manufacturing quotation.